Tebanicline is a synthetic nicotinic analgesic and a less toxic derivative of epibatidine. It functions as a partial agonist at α3β4 and α4β2 neuronal nicotinic acetylcholine receptors. This compound is utilized in research on neuropathic pain mechanisms, employing both in vitro receptor binding assays and in vivo animal models of chronic pain.